426 related articles for article (PubMed ID: 33332590)
1. Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.
Reeve BB; McFatrich M; Lin L; Lucas NR; Mack JW; Jacobs SS; Withycombe JS; Baker JN; Freyer DR; Hinds PS
Cancer; 2021 May; 127(9):1483-1494. PubMed ID: 33332590
[TBL] [Abstract][Full Text] [Related]
2. Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.
Reeve BB; McFatrich M; Mack JW; Maurer SH; Jacobs SS; Freyer DR; Withycombe JS; Baker JN; Castellino SM; Lin L; Lucas NR; Hinds PS
J Natl Cancer Inst; 2020 Nov; 112(11):1143-1152. PubMed ID: 31999349
[TBL] [Abstract][Full Text] [Related]
3. Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment.
Reeve BB; McFatrich M; Mack JW; Pinheiro LC; Jacobs SS; Baker JN; Withycombe JS; Lin L; Mann CM; Villabroza KR; Hinds PS
Pediatr Blood Cancer; 2020 Apr; 67(4):e28160. PubMed ID: 31904157
[TBL] [Abstract][Full Text] [Related]
4. Agreement Between Child Self-report and Caregiver-Proxy Report for Symptoms and Functioning of Children Undergoing Cancer Treatment.
Mack JW; McFatrich M; Withycombe JS; Maurer SH; Jacobs SS; Lin L; Lucas NR; Baker JN; Mann CM; Sung L; Tomlinson D; Hinds PS; Reeve BB
JAMA Pediatr; 2020 Nov; 174(11):e202861. PubMed ID: 32832975
[TBL] [Abstract][Full Text] [Related]
5. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
[TBL] [Abstract][Full Text] [Related]
6. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Dueck AC; Mendoza TR; Mitchell SA; Reeve BB; Castro KM; Rogak LJ; Atkinson TM; Bennett AV; Denicoff AM; O'Mara AM; Li Y; Clauser SB; Bryant DM; Bearden JD; Gillis TA; Harness JK; Siegel RD; Paul DB; Cleeland CS; Schrag D; Sloan JA; Abernethy AP; Bruner DW; Minasian LM; Basch E;
JAMA Oncol; 2015 Nov; 1(8):1051-9. PubMed ID: 26270597
[TBL] [Abstract][Full Text] [Related]
7. Recommended scoring approach for the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events.
Hinds PS; Pinheiro LC; McFatrich M; Waldron M; Baker JN; Mowbray C; Maurer SH; Cheng Y; Reeve BB; Wang J
Pediatr Blood Cancer; 2022 Jun; 69(6):e29452. PubMed ID: 34866311
[TBL] [Abstract][Full Text] [Related]
8. Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials.
Freyer DR; Lin L; Mack JW; Maurer SH; McFatrich M; Baker JN; Jacobs SS; Lucas N; Withycombe JS; Tomlinson D; Villabroza KR; Waldron MK; Hinds PS; Reeve BB
J Clin Oncol; 2022 May; 40(15):1623-1634. PubMed ID: 35294262
[TBL] [Abstract][Full Text] [Related]
9. Development of six PROMIS pediatrics proxy-report item banks.
Irwin DE; Gross HE; Stucky BD; Thissen D; DeWitt EM; Lai JS; Amtmann D; Khastou L; Varni JW; DeWalt DA
Health Qual Life Outcomes; 2012 Feb; 10():22. PubMed ID: 22357192
[TBL] [Abstract][Full Text] [Related]
10. Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events.
Yang SS; Chen L; Liu Y; Lu HJ; Huang BJ; Lin AH; Sun Y; Ma J; Xie FY; Mao YP
BMC Cancer; 2021 Jul; 21(1):860. PubMed ID: 34315423
[TBL] [Abstract][Full Text] [Related]
11. Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.
Reeve BB; McFatrich M; Pinheiro LC; Freyer DR; Basch EM; Baker JN; Withycombe JS; Sung L; Mack JW; Waldron MK; Mowbray C; Palma D; Hinds PS
J Pain Symptom Manage; 2017 Apr; 53(4):759-766. PubMed ID: 28062347
[TBL] [Abstract][Full Text] [Related]
12. Measuring Duchenne muscular dystrophy impact: development of a proxy-reported measure derived from PROMIS item banks.
Schwartz CE; Stark RB; Cella D; Borowiec K; Gooch KL; Audhya IF
Orphanet J Rare Dis; 2021 Nov; 16(1):487. PubMed ID: 34809687
[TBL] [Abstract][Full Text] [Related]
13. Profile Comparison of Patient-Reported and Proxy-Reported Symptoms in Pediatric Patients With Cancer Receiving Chemotherapy.
Weaver MS; Jacobs SS; Withycombe JS; Wang J; Greenzang KA; Baker JN; Hinds PS
JAMA Netw Open; 2022 Mar; 5(3):e221855. PubMed ID: 35348712
[TBL] [Abstract][Full Text] [Related]
14. Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®).
Caminiti C; Bryce J; Riva S; Ng D; Diodati F; Iezzi E; Sparavigna L; Novello S; Porta C; Del Mastro L; Procopio G; Cinieri S; Falzetta A; Calabrò F; Lorusso V; Cogoni AA; Tortora G; Maruzzo M; Passalacqua R; Cognetti F; Adamo V; Capelletto E; Ferrari A; Bagnalasta M; Bassi M; Nicelli A; De Persis D; D'Acunti A; Iannelli Patient E; Perrone F; Mitchell SA
Tumori; 2023 Jun; 109(3):324-334. PubMed ID: 35674125
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events.
Jacobs SS; Withycombe JS; Castellino SM; Lin L; Mack JW; McFatrich M; Baker JN; Freyer DR; Maurer SH; Mowbray C; Hinds PS; Reeve BB
Pediatr Blood Cancer; 2022 Dec; 69(12):e29986. PubMed ID: 36151978
[TBL] [Abstract][Full Text] [Related]
16. Chinese Version of Pediatric Patient-Reported Outcomes Measurement Information System Short Form Measures: Reliability, Validity, and Factorial Structure Assessment in Children With Cancer in China.
Liu Y; Yuan C; Wang J; Shen N; Shen M; Hinds PS
Cancer Nurs; 2019; 42(6):430-438. PubMed ID: 30124482
[TBL] [Abstract][Full Text] [Related]
17. Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events.
Yoon J; Sim SH; Kang D; Han G; Kim Y; Ahn J; Oh D; Lee ES; Kong SY; Cho J; Mitchell SA
J Pain Symptom Manage; 2020 May; 59(5):1082-1088.e6. PubMed ID: 32044423
[TBL] [Abstract][Full Text] [Related]
18. Clinical validity of the PROMIS pediatric sleep short forms in children receiving treatment for cancer.
Daniel LC; Gross JY; Meltzer LJ; Flannery JL; Forrest CB; Barakat LP
Pediatr Blood Cancer; 2020 Sep; 67(9):e28535. PubMed ID: 32649043
[TBL] [Abstract][Full Text] [Related]
19. The longitudinal validity, reproducibility and responsiveness of the Brisbane Burn Scar Impact Profile (caregiver report for young children version) for measuring health-related quality of life in children with burn scars.
Simons M; Kimble R; McPhail S; Tyack Z
Burns; 2019 Dec; 45(8):1792-1809. PubMed ID: 31147101
[TBL] [Abstract][Full Text] [Related]
20. Development and initial validation of the AL-PROfile patient-reported outcome measure in light chain (AL) amyloidosis.
D'Souza A; Szabo A; Akinola I; Finkel M; Flynn KE
Eur J Haematol; 2024 Jun; 112(6):900-909. PubMed ID: 38350661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
